Use of the number needed to treat to evaluate clinical trials of quetiapine and other atypical antipsychotics
Year: 2000
Type: article
Source: European Neuropsychopharmacology
Author: J. Donoghue
Institution: AstraZeneca (United Kingdom)
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2118004996
